Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 82
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
‘A Sea Change’, With Caveats: A Closer Look at Definium’s Phase 3 LSD for MDD Readout
Psychedelic Policy Briefing: Week of June 22nd, 2026
Mike Finoia – The Comedy of Conscious Aging, Episode 16
Breaking: Definium Lands Positive Phase 3, LSD Candidate Shows Strong Antidepressant Effect
The Psychedelic Practitioner Issue 5: Groups in Practice
Disposition of Common Shares of Small Pharma Inc.
GH Research Provides Updates and Guidance on its Clinical Development Program...
PT446 – Decolonization, Interconnection, and the Medicalization of Mysticism
Psychedelic Bulletin #146: Numinus Drops Lab, Consolidates Clinics; Study Suggests DMT...
FILAMENT HEALTH CORP. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT UNIT OFFERING LED BY...
So, You’ve Become a Psychedelic-Informed Practitioner. Now what?
Canadian Veteran Receives Approval for APEX’s Psilocybin Therapy Through Health Canada’s...
PharmaTher Announces FDA Acceptance, As a Priority Original Abbreviated New Drug...
PT445 – The Drug War, Harm Reduction, and the Middle Ground...
Gilgamesh Pharmaceuticals Successfully Completes Phase 1 SAD/MAD Clinical Trials of GM-1020
Load more